Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Pittaluga

Showing results (111-120 of 358) with videos related to

Pageof 36
Sort By:
Blood Advances|August 25, 2021
Next-generation sequencing-based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCLMilos D Miljkovic, Christopher Melani, Stefania Pittaluga, et al.
Frontiers in Pediatrics|March 16, 2017
DOCK 8 Deficiency, EBV+ Lymphomatoid Granulomatosis, and Intrafamilial Variation in PresentationVictoria R Dimitriades, Vincent Devlin, Stefania Pittaluga, et al.
The New England Journal of Medicine|June 12, 2024
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyMetin Ozdemirli, Thomas M Loughney, Emre Deniz, et al.
Leukemia|February 26, 2021
Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemiaDamian Kovalovsky, Jeong Heon Yoon, Matthew G Cyr, et al.
Haematologica|December 18, 2009
C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathwayNatasa Anastasov, Irina Bonzheim, Martina Rudelius, et al.
Leukemia & Lymphoma|June 24, 2017
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-RCatherine Lai, Mark Roschewski, Christopher Melani, et al.
Journal of Clinical Immunology|June 17, 2015
IL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotypeAmy P Hsu, Stefania Pittaluga, Bianca Martinez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 30, 2018
Liver disturbances in activated phosphoinositide 3-kinase δ syndromeGil Ben-Yakov, Devika Kapuria, Jamie Marko, et al.
Frontiers in Immunology|April 4, 2022
Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 VaccinationEmilia Cirillo, Ciro Esposito, Giuliana Giardino, et al.
The American Journal of Surgical Pathology|September 28, 2010
Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progressionHaipeng Shao, Liqiang Xi, Mark Raffeld, et al.
Pageof 36

Showing results (111-120 of 358) with videos related to

Sort By:
Pageof 36
Blood Advances|August 25, 2021
Next-generation sequencing-based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCLMilos D Miljkovic, Christopher Melani, Stefania Pittaluga, et al.
Frontiers in Pediatrics|March 16, 2017
DOCK 8 Deficiency, EBV+ Lymphomatoid Granulomatosis, and Intrafamilial Variation in PresentationVictoria R Dimitriades, Vincent Devlin, Stefania Pittaluga, et al.
The New England Journal of Medicine|June 12, 2024
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyMetin Ozdemirli, Thomas M Loughney, Emre Deniz, et al.
Leukemia|February 26, 2021
Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemiaDamian Kovalovsky, Jeong Heon Yoon, Matthew G Cyr, et al.
Haematologica|December 18, 2009
C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathwayNatasa Anastasov, Irina Bonzheim, Martina Rudelius, et al.
Leukemia & Lymphoma|June 24, 2017
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-RCatherine Lai, Mark Roschewski, Christopher Melani, et al.
Journal of Clinical Immunology|June 17, 2015
IL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotypeAmy P Hsu, Stefania Pittaluga, Bianca Martinez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 30, 2018
Liver disturbances in activated phosphoinositide 3-kinase δ syndromeGil Ben-Yakov, Devika Kapuria, Jamie Marko, et al.
Frontiers in Immunology|April 4, 2022
Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 VaccinationEmilia Cirillo, Ciro Esposito, Giuliana Giardino, et al.
The American Journal of Surgical Pathology|September 28, 2010
Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progressionHaipeng Shao, Liqiang Xi, Mark Raffeld, et al.
Pageof 36